Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus.
暂无分享,去创建一个
Matthew Page | Denise O'Connor | J. Shaw | M. Page | Jonathan Shaw | Marie L Misso | Kristine J Egberts | M. Misso | D. O’Connor | J. Shaw | Denise A. O’Connor
[1] N. Fineberg,et al. A randomized, controlled study of insulin pump therapy in diabetic preschoolers. , 2004, The Journal of pediatrics.
[2] P. Davidson,et al. Reduction in Severe Hypoglycemia With Long-Term Continuous Subcutaneous Insulin Infusion in Type I Diabetes , 1996, Diabetes Care.
[3] T. Deckert,et al. Two-Year Experience with Continuous Subcutaneous Insulin Infusion in Relation to Retinopathy and Neuropathy , 1985, Diabetes.
[4] E. Moberg,et al. Variability of blood glucose levels in patients with type 1 diabetes mellitus on intensified insulin regimens. , 1994, Diabete & metabolisme.
[5] Jacob Cohen. A Coefficient of Agreement for Nominal Scales , 1960 .
[6] V. Ja,et al. Comparative study between the subcutaneous continuous insulin infusion pump and optimized conventional treatment. Effects at 6 months , 1986 .
[7] D. Nathan,et al. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients. , 1996, The American journal of medicine.
[8] R. Bergenstal,et al. Observations on Blood Lipid and Intermediary Metabolite Concentrations During Conventional Insulin Treatment or CSII , 1985, Diabetes.
[9] E. Schleicher,et al. Sustained Normoglycemia and Remission Phase in Newly Diagnosed Type I Diabetic Subjects.Comparison Between Continuous Subcutaneous Insulin Infusion and Conventional Therapy During a One Year Follow-Up , 1987, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[10] D. Bruttomesso,et al. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine , 2008, Diabetic medicine : a journal of the British Diabetic Association.
[11] H. Yki-Järvinen,et al. Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes. , 1984, The Journal of clinical endocrinology and metabolism.
[12] H. Bibergeil1,et al. 36 Months Continuous Subcutaneous Insulin Infusion (CSII) in Insulin Dependent Diabetes (IDDM) - Influence on Early Stages of Retinopathy, Nephropathy and Neuropathy - Psychological Analysis6)8) , 1987, Experimental and clinical endocrinology.
[13] Treatment effects and satisfaction in diabetic patients changing from multiple daily insulin injections to CSII , 2004 .
[14] P. Czernichow,et al. Feasibility of continuous subcutaneous insulin infusion in young diabetic patients. , 1988, Diabete & metabolisme.
[15] K. Alberti,et al. Diurnal plasma profiles of metabolite and hormone concentration in insulin-dependent diabetic patients during conventional insulin treatment and continuous subcutaneous insulin infusion. A controlled study. , 1987, Acta endocrinologica.
[16] H. Beck-Nielsen,et al. Insulin pump treatment: effect on glucose homeostasis, metabolites, hormones, insulin antibodies and quality of life. , 1985, Diabetes research (Edinburgh, Scotland).
[17] M. Karp,et al. Preconceptional diabetes control in insulin-dependent diabetes mellitus patients with continuous subcutaneous insulin infusion therapy , 1987, Journal of perinatal medicine.
[18] J. Pickup,et al. Hypoglycemia and Counterregulation in Insulin-Dependent Diabetic Patients: A Comparison of Continuous Subcutaneous Insulin Infusion and Conventional Insulin Injection Therapy , 1986, Diabetes Care.
[19] K. Hermansen,et al. Effect of pump versus pen treatment on glycaemic control and kidney function in long-term uncomplicated insulin-dependent diabetes mellitus (IDDM). , 1989, Danish medical bulletin.
[20] W. Kerner,et al. Incidence of Hypoglycemic Episodes in Diabetic Patients Under Continuous Subcutaneous Insulin Infusion and Intensified Conventional Insulin Treatment: Assessment by Means of Semiambulatory 24-hour Continuous Blood Glucose Monitoring , 1985, Diabetes Care.
[21] T. Holford,et al. A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies. , 1986, JAMA.
[22] J. Avruch,et al. Intensive conventional and insulin pump therapies in adult type I diabetes. A crossover study. , 1982, Annals of internal medicine.
[23] John Pickup,et al. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials , 2002, BMJ : British Medical Journal.
[24] P. Lönnroth,et al. Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion. , 1983, British medical journal.
[25] E. Kraegen,et al. Hypoglycemic episodes during continuous subcutaneous insulin infusion: decreased frequency but increased susceptibility. , 1984, Australian and New Zealand journal of medicine.
[26] J. Pickup,et al. Patterns of Hyperinsulinaemia in Type 1 Diabetic Patients With and Without Nephropathy , 1989, Diabetic medicine : a journal of the British Diabetic Association.
[27] A. Schiffrin,et al. Feasibility of strict diabetes control in insulin-dependent diabetic adolescents. , 1983, The Journal of pediatrics.
[28] J. Couper. Children with type 1 diabetes: where are we at? , 2002, The Medical journal of Australia.
[29] A. Schiffrin,et al. Intensified Insulin Therapy in the Type I Diabetic Adolescent: A Controlled Trial , 1984, Diabetes Care.
[30] K. Hall,et al. Serum levels of insulin‐like growth factor (IGF) I, II and IGF binding protein in diabetic adolescents treated with continuous subcutaneous insulin infusion , 1989, Journal of internal medicine.
[31] P. Hamet,et al. Continuous Subcutaneous Insulin Infusion (Mill-Hill Infuser) Versus Multiple Injections (Medi-Jector) in the Treatment of Insulin-dependent Diabetes Mellitus and the Effect of Metabolic Control on Microangiopathy , 1984, Diabetes Care.
[32] J. Skogsberg,et al. Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus , 2008, Pediatric diabetes.
[33] W. Tamborlane,et al. Long-term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy. , 1982, Diabetes care.
[34] W. Tamborlane,et al. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. , 1979, The New England journal of medicine.
[35] J. K. Radder,et al. Glucose disposal and intermediary metabolism during one year of continuous subcutaneous insulin infusion (CSII). , 1991, Diabetes research and clinical practice.
[36] G. Pozza,et al. Comparison between multi-injection and continuous subcutaneous insulin therapy in insulin-dependent diabetic inpatients , 2005, Acta diabetologia latina.
[37] H. Tritschler,et al. Hydroperoxides in Plasma Are Reduced by Intensified Insulin Treatment: A randomized controlled study of IDDM patients with microalbuminuria , 1998, Diabetes Care.
[38] A. Galatzer,et al. Comparison of metabolic and psychological parameters during continuous subcutaneous insulin infusion and intensified conventional insulin treatment in type I diabetic patients. , 1985, Israel journal of medical sciences.
[39] K. Dahl-Jørgensen,et al. The response of diabetic retinopathy to 41 months of multiple insulin injections, insulin pumps, and conventional insulin therapy. , 1988, Archives of ophthalmology.
[41] D. Sutherland,et al. Long-Term, Ambulatory, Subcutaneous Insulin Infusion versus Multiple Daily Injections in Brittle Diabetic Patients , 1981, Diabetes Care.
[42] J. Ioannidis,et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].
[43] B. Zinman,et al. Overnight Metabolic Control with Pulsed Intermittent Versus Continuous Subcutaneous Insulin Infusion , 1983, Diabetes Care.
[44] G. Borsboom,et al. Effects of insulin pump vs. injection treatment on quality of life and impact of disease in children with type 1 diabetes mellitus in a randomized, prospective comparison , 2008, Pediatric diabetes.
[45] H. E. Hansen,et al. Metabolic control in newly kidney transplanted insulin-dependent diabetics: improvement by insulin pump treatment (CSII). , 1987, The Journal of diabetic complications.
[46] J. Tuomilehto,et al. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. , 2000, Diabetes care.
[47] K. DAHL‐JØRGENSEN,et al. Continuous subcutaneous insulin infusion (CSII), multiple injections (MI) and conventional insulin therapy (CT) in self‐selecting insulin‐dependent diabetic patients. A comparison of metabolic control, acute complications and patient preferences , 1990, Journal of internal medicine.
[48] R. Osterby,et al. Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy , 1994, Diabetologia.
[49] I. Hirsch,et al. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. , 2005, Diabetes care.
[50] N. Saurbrey,et al. Preconceptional treatment with insulin infusion pumps in insulin-dependent diabetic women with particular reference to prevention of congenital malformations. , 1986, Acta endocrinologica. Supplementum.
[51] K S Johansen,et al. The WHO (Ten) Well-Being Index: validation in diabetes. , 1996, Psychotherapy and psychosomatics.
[52] R. Rizza,et al. Diabetic retinopathy after two years of intensified insulin treatment. Follow-up of the Kroc Collaborative Study. The Kroc Collaborative Study Group. , 1988, JAMA.
[53] C. de Beaufort,et al. Psychological impact of continuous subcutaneous insulin infusion pump therapy in non-selected newly diagnosed insulin dependent (type 1) diabetic children: evaluation after two years of therapy. , 1990, Diabete & metabolisme.
[54] A. Schiffrin,et al. Accommodating Planned Exercise in Type I Diabetic Patients on Intensive Treatment , 1985, Diabetes Care.
[55] M. Silink,et al. The Incidence of Childhood IDDM in New South Wales, Australia , 1994, Diabetes Care.
[56] R L Hintz,et al. Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels. , 1981, The New England journal of medicine.
[57] S. Shalitin,et al. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion. , 2004, Archives of pediatrics & adolescent medicine.
[58] V. Koivisto,et al. Postprandial Blood Glucose Response to Exercise in Type I Diabetes: Comparison Between Pump and Injection Therapy , 1983, Diabetes Care.
[59] P. Watkins,et al. Intermittent clinical proteinuria and renal function in diabetes: evolution and the effect of glycaemic control. , 1986 .
[60] T. Kuno,et al. Continuous subcutaneous insulin injection for self‐care of young patients with insulin‐dependent diabetes mellitus , 1996, Acta paediatrica Japonica : Overseas edition.
[61] M. Massobrio,et al. Continuous subcutaneous insulin infusion versus intensive conventional insulin therapy in type I and type II diabetic pregnancy. , 1986, Diabete & metabolisme.
[62] A. Schiffrin,et al. Metabolic Response to Fasting Exercise in Adolescent Insulin-Dependent Diabetic Subjects Treated with Continuous Subcutaneous Insulin Infusion and Intensive Conventional Therapy , 1984, Diabetes Care.
[63] K. Alberti,et al. Continuous subcutaneous insulin Infusion: Good blood glucose control for up to 4 days , 1979, Diabetologia.
[64] R. DeFronzo,et al. Improved Insulin Sensitivity in Patients with Type I Diabetes Mellitus After CSII , 1985, Diabetes.
[65] B. Bode,et al. Patient Perception and Use of an Insulin Injector/Glucose Monitor Combined Device , 2004, The Diabetes educator.
[66] Kyuzi Kamoi,et al. A quality-of-life assessment of intensive insulin therapy using insulin lispro switched from short-acting insulin and measured by an ITR-QOL questionnaire: a prospective comparison of multiple daily insulin injections and continuous subcutaneous insulin infusion. , 2004, Diabetes research and clinical practice.
[67] W. Tamborlane,et al. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. , 2004, Diabetes care.
[68] Torsten Deckert,et al. EFFECT OF TWO YEARS OF STRICT METABOLIC CONTROL ON PROGRESSION OF INCIPIENT NEPHROPATHY IN INSULIN-DEPENDENT DIABETES , 1986, The Lancet.
[69] S. Marshall,et al. Continuous Subcutaneous Insulin Infusion Versus Injection Therapy: A Randomized Cross‐over Trial Under Usual Diabetic Clinic Conditions , 1987, Diabetic medicine : a journal of the British Diabetic Association.
[70] B. Zinman,et al. Counterregulatory Hormone Responses Preserved After Long-Term Intravenous Insulin Infusion Compared to Continuous Subcutaneous Insulin Infusion , 1988, Diabetes.
[71] E. Gale,et al. Intervening before the onset of Type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT) , 2003, Diabetologia.
[72] T. Olsen,et al. Effect of Insulin Pump Treatment for One Year on Renal Function and Retinal Morphology in Patients with IDDM , 1985, Diabetes Care.
[73] B. Guerci,et al. Blood glucose control on Sunday in IDDM patients: intensified conventional insulin therapy versus continuous subcutaneous insulin infusion. , 1998, Diabetes research and clinical practice.
[74] K. Hermansen,et al. Effect of continuous subcutaneous insulin infusion on kidney function and size in IDDM patients: a 2 year controlled study. , 1987, The Journal of diabetic complications.
[75] G. Bruining,et al. Continuous Subcutaneous Insulin Infusion (CSII) Versus Conventional Injection Therapy in Newly Diagnosed Diabetic Children: Two‐year Follow‐up of a Randomized, Prospective Trial , 1989, Diabetic medicine : a journal of the British Diabetic Association.
[76] P. Haug,et al. A self-controlled study of the effect of continuous subcutaneous insulin infusion on diabetic neuropathy , 1987, Journal of the Neurological Sciences.
[77] G. Dimitriadis,et al. Integration of biochemical and physiologic effects of insulin on glucose metabolism. , 2001, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[78] J. Huttunen,et al. A crossover comparison of continuous insulin infusion and conventional injection treatment of type I diabetes. , 2009, Acta medica Scandinavica.
[79] J. Ketelslegers,et al. Comparison of Plasma Glucose and Plasma Free Insulin During CSII and Intensified Conventional Insulin Therapy , 1983, Diabetes Care.
[80] T. Olsen,et al. Diabetic retinopathy after one year of improved metabolic control obtained by continuous subcutaneous insulin infusion (CSII) , 1985, Acta ophthalmologica.
[81] J. Hoekstra,et al. Comparison between multiple daily insulin injection therapy (MDI) and continuous subcutaneous insulin infusion therapy (CSII), results of the five nations study , 2006 .
[82] K. Hermansen,et al. Exercise capacity and cardiac function in type 1 diabetic patients treated with continuous subcutaneous insulin infusion. A controlled study. , 1986, Scandinavian journal of clinical and laboratory investigation.
[83] J. Jakobsen,et al. Autonomic and Somatosensory Nerve Function After 2 Years of Continuous Subcutaneous Insulin Infusion in Type I Diabetes , 1988, Diabetes.
[84] J. Grimm,et al. Lifestyle, metabolic control and social implications of pump therapy in 54 routine type I diabetic patients. , 1987, Diabete & metabolisme.
[85] C. Canny,et al. Comparison of Stereofundus Photographs in Patients with Insulin-dependent Diabetes During Conventional Insulin Treatment or Continuous Subcutaneous Insulin Infusion , 1985, Diabetes.
[86] Jonathan A C Sterne,et al. Investigating and Dealing with Publication and Other Biases , 2008 .
[87] P. Brunetti,et al. Continuous subcutaneous insulin infusion treatment in insulin-dependent diabetic patients: a comparison with conventional optimized treatment in a long-term study. , 1982, Diabetes care.
[88] L. Monnier,et al. Effects of different insulin administration modalities on vitamin D metabolism of insulin-dependent diabetic patients. , 1986, Advances in experimental medicine and biology.
[89] E. Parton,et al. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes. , 2005, Diabetes technology & therapeutics.
[90] K. Hermansen,et al. The Effect of Six Months Continuous Subcutaneous Insulin Infusion on Kidney Function and Size in Insulin‐dependent Diabetics , 1986, Diabetic Medicine.
[91] K. Dahl-Jørgensen,et al. Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study. , 1988, Acta endocrinologica.
[92] K. Dahl-Jørgensen,et al. Oscillatory potentials, macular recovery time, and diabetic retinopathy through 3 years of intensified insulin treatment. , 1988, Ophthalmology.
[93] N. Saurbrey,et al. Comparison of Continuous Subcutaneous Insulin Infusion with Multiple Insulin Injections Using the NovoPen , 1988, Diabetic medicine : a journal of the British Diabetic Association.
[94] R. Heine,et al. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. , 2002, Diabetes care.
[95] J C Pickup,et al. A new approach to improved metabolic control in diabetics: continuous subcutaneous insulin infusion. , 1980, American heart journal.
[96] U. Smith,et al. Altered Recognition of Hypoglycaemic Symptoms in Type I Diabetes during Intensified Control with Continuous Subcutaneous Insulin Infusion , 1986, Diabetic medicine : a journal of the British Diabetic Association.
[97] J. Pickup,et al. Urinary Insulin Excretion Rate: An Index of Free Insulinaemia in Insulin‐dependent Diabetics , 1984, Diabetic medicine : a journal of the British Diabetic Association.
[98] P. Raskin,et al. The Effect of Continuous Subcutaneous Insulin Infusion on Very-Low-Density Lipoprotein Triglyceride Metabolism in Type I Diabetes Mellitus , 1983, Diabetes.
[99] P. Davidson,et al. Evaluation of the psychosocial impact of the MiniMed variable-rate implantable insulin pump. , 1995, Southern medical journal.
[100] D. Hadden,et al. Effect of plasma glucose control by continuous subcutaneous insulin infusion on nerve conduction , 1985, Irish journal of medical science.
[101] L. Hegedüs,et al. Kidney function during 12 months of strict metabolic control in insulin-dependent diabetic patients with incipient nephropathy. , 1986, The New England journal of medicine.
[102] W. Tamborlane,et al. Persistence of Benefits of Continuous Subcutaneous Insulin Infusion in Very Young Children With Type 1 Diabetes: A Follow-up Report , 2004, Pediatrics.
[103] T. Olsen,et al. Diabetic retinopathy after 3 years' treatment with continuous subcutaneous insulin infusion (CSII) , 1987, Acta ophthalmologica.
[104] K. Alberti,et al. A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSII. , 1982, Diabetes care.
[105] G. Deja,et al. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus]. , 2005, Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych.
[106] F. Nicoletti,et al. Effect of octreotide on blood glucose and counterregulatory hormones in insulin-dependent diabetic patients: the role of dose and route of administration , 1996, European Journal of Clinical Pharmacology.
[107] H. Beck-Nielsen,et al. Effect of near normoglycemia for 5 years on progression of early diabetic retinopathy and renal involvement. , 1990, Diabetes research.
[108] R. Tilvis,et al. Improvement of diabetic control by continuous subcutaneous insulin infusion therapy changes fatty acid composition of serum lipids and erythrocytes in Type 1 (insulin-dependent) diabetes , 1986, Diabetologia.
[109] M. Spraul,et al. Die Behandlung des Typ I-Diabetes mellitus mit der kontinuierlichen subkutanen Insulininfusion (CSII): Indikationen und Qualitätskontrolle , 1989 .
[110] Clinical Predictors of Retinopathy and Its Progression in Patients with Type I Diabetes During CSII or Conventional Insulin Treatment , 1985, Diabetes.
[111] V. Koivisto,et al. A controlled study of the influence of continuous subcutaneous insulin infusion treatment on diabetic retinopathy during pregnancy. , 2009, Acta medica Scandinavica.
[112] H. Beck-Nielsen,et al. Improved In Vivo Insulin Effect During Continuous Subcutaneous Insulin Infusion in Patients with IDDM , 1984, Diabetes.
[113] G. Sanborn,et al. Effect of insulin infusion pump use on diabetic retinopathy. , 1984, Archives of ophthalmology.
[114] K. Alberti,et al. Metabolic effects of physical exercise in insulin-dependent diabetics controlled by continuous subcutaneous insulin infusion or conventional injection therapy. , 1984, Acta endocrinologica.
[115] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[116] K. Alberti,et al. Glucagon responses to intravenous arginine and oral glucose in insulin-dependent diabetic patients during six months conventional or continuous subcutaneous insulin infusion. , 1988, Metabolism: clinical and experimental.
[117] Douglas G Altman,et al. Systematic reviews in health care: Assessing the quality of controlled clinical trials. , 2001, BMJ.
[118] K. Irsigler,et al. Implanted constant basal rate insulin infusion devices for type 1 (Insulin-dependent) diabetic patients , 1983, Diabetologia.
[119] J. Rosenstock,et al. The effect of continuous subcutaneous insulin infusion on serum lipids. , 1984, Diabete & metabolisme.
[120] R. Bilous,et al. Correction of Exercise-induced Microalbuminuria in Insulin-dependent Diabetics After 3 Weeks of Subcutaneous Insulin Infusion , 1981, Diabetes.
[121] A. Schiffrin,et al. Comparison Between Continuous Subcutaneous Insulin Infusion and Multiple Injections of Insulin: A One-Year Prospective Study , 1982, Diabetes.
[122] A. Berghold,et al. Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy , 2004, Diabetologia.
[123] Dana Dabelea,et al. The accelerating epidemic of childhood diabetes , 2009, The Lancet.
[124] F. Gries,et al. Effects of one year of near-normoglycemia on peripheral nerve function in type 1 (insulin-dependent) diabetic patients , 1988, Klinische Wochenschrift.
[125] The treatment of unstable type I diabetes: Conventional versus portable pump insulin administration , 1983, Acta diabetologia latina.
[126] I. Mühlhauser,et al. Intensified treatment and education of type 1 diabetes as clinical routine. A nationwide quality-circle experience in Germany. ASD (the Working Group on Structured Diabetes Therapy of the German Diabetes Association). , 1999, Diabetes care.
[127] D. Hadden,et al. The effect of plasma glucose control by continuous subcutaneous insulin infusion or conventional therapy on retinal morphology and urinary albumin excretion. , 1985, Diabete & metabolisme.
[128] R. Mecklenburg,et al. Factors Related to Discontinuation of Continuous Subcutaneous Insulin-Infusion Therapy , 1988, Diabetes Care.
[129] R. Rizza,et al. The Pump Life: Patient Responses and Clinical and Technological Problems , 1985, Diabetes.
[130] P. Schaepelynck-Belicar,et al. Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS). , 2003, Diabetes & metabolism.
[131] O. Kordonouri,et al. Age-specific advantages of continuous subcutaneous insulin infusion as compared with multiple daily injections in pediatric patients: one-year follow-up comparison by matched-pair analysis. , 2006, Diabetes care.
[132] L. Merenmies,et al. Continuous insulin infusion therapy and retinopathy in patients with type I diabetes. , 1987, Acta endocrinologica.
[133] Darrell M. Wilson,et al. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. , 2005, Diabetes care.
[134] B. Fielding,et al. Continuous subcutaneous insulin infusion in diabetes mellitus. A year's prospective trial. , 1984, Archives of disease in childhood.
[135] L. Egede,et al. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes. , 2003, The Journal of pediatrics.
[136] W. Tamborlane,et al. RESTORATION OF NORMAL LIPID AND AMINOACID METABOLISM IN DIABETIC PATIENTS TREATED WITH A PORTABLE INSULIN-INFUSION PUMP , 1979, The Lancet.
[137] M. Taskinen,et al. Effects of continuous insulin infusion therapy on lipoprotein surface and core lipid composition in insulin-dependent diabetes mellitus. , 1991, Metabolism: clinical and experimental.
[138] A. Schiffrin,et al. Multiple daily self-glucose monitoring: its essential role in long-term glucose control in insulin-dependent diabetic patients treated with pump and multiple subcutaneous injections. , 1982, Diabetes care.
[139] K. Hermansen,et al. Near normoglycemia for 1 year has no effect on platelet reactivity, factor VIII, and von Willebrand factor in insulin-dependent diabetes mellitus: a controlled trial. , 1987, The Journal of diabetic complications.
[140] R. Mecklenburg,et al. Clinical use of the insulin infusion pump in 100 patients with type I diabetes. , 1982, New England Journal of Medicine.
[141] R. Trevisan,et al. Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment. , 2003, Diabetes care.
[142] G. Ghirlanda,et al. A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8). , 2003, Diabetes technology & therapeutics.
[143] P. Hamet,et al. Effects of Continuous Subcutaneous Insulin Infusion Versus Multiple Injections on Insulin Receptors in Insulin-Dependent Diabetics , 1987, Diabetes Care.
[144] J. R. Daube,et al. Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy , 1985, Diabetologia.
[145] K. Dahl-Jørgensen,et al. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. , 1985, British medical journal.
[146] Leiv Sandvik,et al. Long-term glycemie control and kidney function in insulin-dependent diabetes mellitus , 1992 .
[147] T. R. Taylor,et al. Changes in cognitive and social functioning of diabetic patients following initiation of insulin infusion therapy. , 2007, Experimental aging research.
[148] K. Dahl-Jørgensen. Near-normoglycemia and late diabetic complications. The Oslo Study. , 1987, Acta endocrinologica. Supplementum.
[149] D. Heber,et al. Low-dose continuous insulin therapy for diabetic ketoacidosis. Prospective comparison with "conventional" insulin therapy. , 1977, Archives of internal medicine.
[150] A. Lanzone,et al. Continuous subcutaneous insulin infusion (CSII) in pregnant diabetic women. , 1986, Acta endocrinologica. Supplementum.
[151] V. Lotter,et al. Follow-Up Studies , 1978 .
[152] P. Scuffham,et al. The cost‐effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes , 2003, Diabetic medicine : a journal of the British Diabetic Association.
[153] N. Sulli,et al. Continuous Subcutaneous Insulin Infusion in Children and Adolescents with Diabetes Mellitus: Decreased HbA1c with Low Risk of Hypoglycemia , 2003, Journal of pediatric endocrinology & metabolism : JPEM.
[154] K. Dahl-Jørgensen,et al. Plasma somatostatin and plasma glucagon in long-term IDDM without residual B-cell function. No effect of different long-term metabolic control. , 1986, Scandinavian journal of clinical and laboratory investigation.
[155] A. Boulton,et al. Long term glycaemic control by alternative regimens in a feasibility study of continuous subcutaneous insulin infusion. , 1986, Diabetes research (Edinburgh, Scotland).
[156] A H Clemens,et al. Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. , 1980, The New England journal of medicine.
[157] Alejandro R. Jadad,et al. Randomized controlled trials , 2007 .
[158] N. Rodger,et al. Comparison of platelet thromboxane synthesis in diabetic patients on conventional insulin therapy and continuous insulin infusions. , 1982, Thrombosis research.
[159] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[160] N. Waugh,et al. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. , 2004, Health technology assessment.
[161] E. Helve. High density lipoprotein subfractions during continuous insulin infusion therapy. , 1987, Atherosclerosis.
[162] Johan P Mackenbach,et al. Income inequality and population health , 2002, BMJ : British Medical Journal.
[163] K. Hermansen,et al. Lipoprotein changes during continuous subcutaneous insulin infusion in insulin-dependent diabetic patients. , 1986, Scandinavian journal of clinical and laboratory investigation.
[164] H. Chase,et al. Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump. , 2004, Diabetes technology & therapeutics.
[165] Johnny Ludvigsson,et al. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. , 2003, Pediatrics.
[166] H. Beck-Nielsen,et al. Multiple insulin injections using a pen injector versus insulin pump treatment in young diabetic patients. , 1987, Diabetes research.
[167] A. Donker,et al. The effect of continuous subcutaneous insulin infusion on renal function in type I diabetic patients with and without proteinuria. , 1985, Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress.
[168] N. Rodger,et al. Continuous Subcutaneous Insulin Infusion in Adults: Glycemic Advantage is Predicted by Venous Plasma C-Peptide Concentrations , 1985, Diabetes Care.
[169] Does continuous subcutaneous insulin infusion (CSII) prolong the remission phase of insulin-dependent diabetic children? Preliminary findings of a randomized prospective study. , 1985, The Netherlands journal of medicine.
[170] K. Alberti,et al. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION: IMPROVED BLOOD-GLUCOSE AND INTERMEDIARY-METABOLITE CONTROL IN DIABETICS , 1979, The Lancet.
[171] S. Toni,et al. The use of insulin pumps improves the metabolic control in children and adolescents with type 1 diabetes , 2004, Archives of Disease in Childhood.
[172] J. Tauber,et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes. , 2000, Diabetes care.
[173] T. Vos,et al. Cost-Effectiveness of Interventions to Promote Physical Activity: A Modelling Study , 2009, PLoS medicine.
[174] H. Rasmussen,et al. Physiology and Pathophysiology of Insulin Secretion , 1990, Diabetes Care.
[175] J. Skyler,et al. Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion. , 1982, The American journal of medicine.
[176] Jonathan A C Sterne,et al. Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. , 2001, BMJ.
[177] S. Greene,et al. Clinical application of insulin pumps in the management of insulin dependent diabetes. , 1983, Archives of disease in childhood.
[178] M. Thompson,et al. The Minnesota Diabetes Complications Clinical Trial cognitive functions under long-term maximized and standard metabolic controls. , 1984, Diabete & metabolisme.
[179] K. Dahl-Jørgensen,et al. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. , 1986, British medical journal.
[180] V. Preedy,et al. Randomized Controlled Trial , 2010 .
[181] R. Rizza,et al. Observations on C-Peptide and Free Insulin in the Blood During Continuous Subcutaneous Insulin Infusion and Conventional Insulin Therapy , 1985, Diabetes.
[182] T. Kobayashi,et al. Plasma Immunoreactive Somatostatin Response to Arginine After Glycemic Control With Continuous Subcutaneous Insulin Infusion in Type I Diabetics , 1987, Diabetes Care.
[183] R. Trevisan,et al. Effect of continuous subcutaneous insulin infusion vs multiple daily insulin injection with glargine as basal insulin: an open parallel long-term study. , 2004, Diabetes, nutrition & metabolism.
[184] M. Freemark,et al. Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. , 2002, The Journal of pediatrics.
[185] M. Phillip,et al. Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections in Adolescents with Type I Diabetes Mellitus: A Randomized Open Crossover Trial , 2003, Journal of pediatric endocrinology & metabolism : JPEM.
[186] M. Craig,et al. The Rising Incidence of Childhood Type 1 Diabetes in New South Wales, Australia , 2000, Journal of pediatric endocrinology & metabolism : JPEM.
[187] B. Feldt-Rasmussen,et al. Effect of improved metabolic control on loss of kidney function in Type 1 (insulin-dependent) diabetic patients: an update of the Steno studies , 1991, Diabetologia.
[188] H. Beck-Nielsen,et al. Antithrombin III activity, von Willebrand factor antigen and platelet function in young diabetic patients treated with multiple insulin injections versus insulin pump treatment , 1989, European journal of clinical investigation.
[189] A. Plant,et al. Services and cost of hospitalization for children and adolescents with insulin‐dependent diabetes mellitus in New South Wales , 1990, The Medical journal of Australia.
[190] A. Schiffrin,et al. Predicting nocturnal hypoglycemia in patients with type I diabetes treated with continuous subcutaneous insulin infusion. , 1987, The American journal of medicine.
[191] K. Dahl-Jørgensen,et al. Effects of intensified insulin treatment on various lesions of diabetic retinopathy. , 1985, American journal of ophthalmology.
[192] L. Beccaria,et al. Short-term subcutaneous insulin infusion in diabetic children. Comparison with three daily insulin injections , 1982, Acta diabetologia latina.
[193] P. Raskin,et al. The Effect of Improved Diabetic Control on Plasma Lipid and Lipoprotein Levels: A Comparison of Conventional Therapy and Continuous Subcutaneous Insulin Infusion , 1980, Diabetes.
[194] J. Hoekstra,et al. Quality of life and metabolic control in patients with diabetes mellitus type 1 treated by continuous subcutaneous insulin infusion or multiple daily insulin injections. , 2004, The Netherlands journal of medicine.
[195] K. Dahl-Jørgensen,et al. Increase in Insulin Antibodies During Continuous Subcutaneous Insulin Infusion and Multiple-Injection Therapy in Contrast to Conventional Treatment , 1987, Diabetes.
[196] G. Forlani,et al. Effect of long-term near-normoglycemia on the progression of diabetic nephropathy. , 1985, Diabete & metabolisme.
[197] J. Skyler,et al. A comparison of insulin regimens in insulin-dependent diabetes mellitus. , 1982, Diabetes care.
[198] K. Dahl-Jørgensen,et al. Early morning glycaemia and the metabolic consequences of delaying breakfast/morning insulin. A comparison of continuous subcutaneous insulin infusion and multiple injection therapy with human isophane or human ultralente insulin at bedtime in insulin-dependent diabetics. , 1989, Scandinavian journal of clinical and laboratory investigation.
[199] D. Bruttomesso,et al. Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy , 2003, Acta Diabetologica.
[200] J. Mendell,et al. Comparison of the effects of continuous subcutaneous infusion and split-mixed injection of insulin on nerve function in type I diabetes mellitus , 1987, Journal of the Neurological Sciences.
[201] B. Zinman,et al. Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection. , 2001, Diabetes care.